금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
India’s central bank tries to shore up rupee as it nears record lows
Rise in energy costs due to US-Israel war on Iran has put downward pressure on the currency of the w...
Where could stocks and bonds collide? Here’s what to watch
Investing.com -- U.S. stocks have historically held up well even as bond yields rise, but a prolonge...
US warns Kyiv that strikes on Russia jeopardise intelligence-sharing
Donald Trump’s administration delivered threat after Volodymyr Zelenskyy criticised diesel deal with...
T. Rowe Price (TROW) Surpasses Market Returns: Some Facts Worth Knowing
T. Rowe Price (TROW) closed at $105.51 in the latest trading session, marking a +1.19% move from the prior day.
Why Griffon (GFF) Outpaced the Stock Market Today
Griffon (GFF) reached $98.39 at the closing of the latest trading day, reflecting a +1.92% change compared to its last close.
Equinix (EQIX) Stock Dips While Market Gains: Key Facts
Equinix (EQIX) closed the most recent trading day at $1, moving 2.58% from the previous trading session.
Copart, Inc. (CPRT) Stock Drops Despite Market Gains: Important Facts to Note
Copart, Inc. (CPRT) reached $27.59 at the closing of the latest trading day, reflecting a -1.6% change compared to its last close.
Pagaya Technologies Ltd. (PGY) Stock Dips While Market Gains: Key Facts
Pagaya Technologies Ltd. (PGY) concluded the recent trading session at $17.62, signifying a -5.88% move from its prior day's close.
Dynatrace (DT) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest trading session, Dynatrace (DT) closed at $57.95, marking a -1.24% move from the previous day.
Astera Labs, Inc. (ALAB) Exceeds Market Returns: Some Facts to Consider
In the closing of the recent trading day, Astera Labs, Inc. (ALAB) stood at $364.62, denoting a +1.14% move from the preceding trading day.
Stock Market Today, Sept. 25: Nike Downgraded by Bank of America, Shares Flat
On Sept. 25, 2026, the analyst firm slashed its price target to $30 from $47, citing weak wholesale momentum and China sales challenges.
Calidi Biotherapeutics gets NYSE compliance warning but stock surprises
Facebook loses high-profile case in New Mexico over deceiving users
Merck pulls BLA for antibody-drug conjugate I-DXd for small cell lung cancer